<DOC>
	<DOC>NCT01404923</DOC>
	<brief_summary>The purpose of this study is to compare the effectiveness of 2 IBS treatment strategies: - Strategy A = MeteoSpasmyl®, on-demand therapy - Strategy B = standard of care chosen by the physician</brief_summary>
	<brief_title>Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Parasympatholytics</mesh_term>
	<mesh_term>Alverine</mesh_term>
	<mesh_term>Mebeverine</mesh_term>
	<criteria>male or female ambulatory patients, aged &gt;= 18 years with IBS as defined by Rome III criteria for more than 1 year and less than 10 years with a IBSSSS between 175 and 400 Acute diarrhea, bowel disorders due to an underlying cause Patient treated with MeteoSpasmyl® within the past 6 months Recent history of gastro intestinal surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>